The NHLBI Division of Intramural Research (DIR) is pleased to welcome two new, highly talented investigators into its ranks. Drs. Susan Harbison and J. Robert Hogg recently joined the DIR as part of the NIH's second recruitment round for Earl Stadtman tenure-track investigators.
A consortium of federal agencies and non-governmental organizations has published a report recommending a set of standard definitions and data collection methods to be used in asthma clinical studies across seven key outcomes, including symptoms, exacerbations such as asthma attacks, biomarkers, and quality of life.
The late sickle cell disease pioneer Charles F. Whitten, M.D., was honored at Lister Hill Auditorium on Feb. 2 with a lecture given by his daughter, Wanda Whitten-Shurney, M.D. The presentation marked the National Library of Medicine's acquisition of Whitten's papers. The gift and the lecture were first announced during the NHLBI's James B. Herrick Symposium in Nov. 2010.
With the fifth annual Rare Disease Day nearly upon us — it is scheduled for this Wednesday, Feb. 29 — I began to reflect on some of the successful NHLBI collaborations with public interest organizations focused on rare diseases that I have seen over my (long) career with the Institute, which welcomes collaboration on any cardiovascular, lung, blood, or sleep manifestation of a disease.
As part of American Heart Month, on Feb. 8 the NHLBI's The Heart TruthÂ® campaign, with the support of the Foundation for the National Institutes of Health, showcased the Red Dress Collection 2012 at Mercedes-Benz Fashion Week in New York City.
The NHLBI Division of Intramural Research honored eight research labs, as well as members of the Clinical Investigators Working Group and the Proteomics Research Core, at the inaugural Orloff Science Awards in the NIH's Lipsett Amphitheater on Jan. 20.
Today is National Wear Red Day® 2012. Here on the NIH campus, we held the first National Wear Red Day "flash mob." Led by passionate staff members, we gathered in the NIH Clinical Center to send a thank-you message to the incredible teams—scientists, doctors, nurses, clinical trial participants, educators, volunteers, and many others across the country—who are working to advance heart disease research and clinical care.
February marks American Heart Month, a time to reflect on the sobering fact that heart disease remains the #1 killer of American women and men—and a time to celebrate those who are working to advance heart disease research and care as well as raise awareness of heart disease risk factors and ways to reduce them.
February marks American Heart Month, a time to reflect on the sobering fact that heart disease remains the #1 killer of American women and men—and a time to celebrate those who are working to advance heart disease research and care as well as raise awareness of heart disease risk factors and ways to reduce them. This month, the NHLBI reaffirms its commitment to helping Americans take steps to reduce their risk of developing heart disease.